India has launched its first AI-based framework, 'OncoMark', which can predict the behaviour and aggressiveness of tumours to guide personalised treatment for cancer patients. OncoMark achieved over 99% accuracy in internal testing and was validated on 20,000 real-world patient samples from eight datasets. It analysed 3.1 million single cells across 14 cancer types during its development.